Peptide Handling Guides: Reconstitution Arithmetic, Storage and Testing

By What Peptides Editorial Team · Updated 2026-09-14 · Pillar guide

This hub collects the arithmetic behind peptide handling: how much diluent a vial needs to reach a stated concentration, how to convert between mass, volume and the graduations printed on a syringe barrel, how lyophilised material is made and stored, and how to read a certificate of analysis. Everything on it is educational arithmetic and label literacy for laboratory and research documentation. It is not a protocol for preparing or administering anything to a person or an animal. Peptides sold through the research channel are typically labelled research use only or not for human consumption; that wording is a statement about the seller's declared intended use, not a description of quality, and it does not turn the material into a licensed medicine.

Most of the searches that reach these pages are arithmetic questions wearing other clothes. Someone types a peptide name and a vial size and wants a number. The honest answer is a concentration: the mass of material in the vial divided by the volume of liquid added to it. That is c = m / V, and once you can compute it, every downstream figure on a label becomes checkable rather than borrowed from a forum post. Three inputs decide the answer: the mass stated on the vial, the diluent volume you choose, and the net peptide content, which is not the same as the gross mass of powder in the vial. Confusing the third with the first is the most common source of a confidently wrong answer.

The guides below split the subject into five problems: the concentration calculation itself, the unit conversions that surround it, the cold-chain conventions for powders and solutions, what a freeze-dried cake tells you and what it does not, and how purity and identity are actually measured. The place to start is the concentration calculation worked from a vial label. Two related hubs carry the surrounding context: the chemistry of the molecules themselves and what a supplier's paperwork can and cannot show.

What These Guides Are and Are Not

A vial of lyophilised peptide bought through a research supplier sits in a different regulatory category from a medicine dispensed by a pharmacy. In the United States, the FDA states plainly that compounded drugs are not FDA-approved and that it does not verify their safety, effectiveness or quality before marketing. A research-use-only label goes further and declares that the material is not intended for use in humans at all. The same molecular entity can of course be the subject of an approved medicine elsewhere in the supply chain; the difference is the licence, the manufacturing inspection, the batch release testing and the pharmacovigilance, not the sequence on the page. If a question concerns a person rather than a vial, the only responsible next step is a licensed clinician and your national regulator, whether that is the FDA, the EMA or MHRA, the TGA or Health Canada.

That is the reason this hub publishes arithmetic rather than protocols. A concentration calculation is dose-agnostic: 10 mg dissolved in 2.00 mL of diluent is 5.00 mg/mL no matter who is holding the syringe, and the number is either right or wrong on its own terms. A preparation protocol is not dose-agnostic at all. It depends on aseptic technique, a qualified environment, materials tested for sterility and endotoxin, documented beyond-use dating under standards such as USP General Chapter 797, and clinical judgement about an individual that no web page can supply. A paragraph on the internet is not a substitute for any of that. What can be supplied honestly is the maths that makes a label legible, which is why pages whose search phrase contains a dosage word are handled here as unit-conversion problems, in the same spirit as the conversion arithmetic behind a dose keyword.

Two consequences follow for anyone reading the pages underneath this one. The first is that no quantity here is attached to a person, a body weight, a schedule or a route; a milligram figure appears only as a property of a vial or a solution. The second is that nothing here should be read as a safety or sterility assurance. A high purity number describes one chromatographic run; a clean-looking cake describes the drying cycle; neither describes microbiology. Readers who want that side of the question should start with the regulatory and sterility questions around injectable peptides and with the wellness cluster's treatment of safety and status.

• No quantities per person or per kilogram of body weight, and no schedules, frequencies or cycle lengths.
• No route-of-administration instructions, no site selection, no needle or drawing technique.
• No titration language, no starting or ceiling amounts, no escalation patterns.
• No step-by-step preparation procedure: volumes appear only as worked arithmetic with abstract numbers.
• No sterility, endotoxin or safety assurance inferred from a purity percentage or a good-looking cake.
• No vendor endorsement: a company name appears only as an illustration of what a document may contain.

Reconstitution Arithmetic: Mass, Volume, Concentration

The whole subject rests on one relation: concentration equals mass divided by volume, c = m / V, with mass in milligrams and volume in millilitres giving mg/mL. A 10 mg vial taken up in 2.00 mL of diluent is 10 / 2.00 = 5.00 mg/mL. A 15 mg vial taken up in 3.00 mL is 5.00 mg/mL as well, which is the first useful lesson: two vials with different contents can produce identical solutions, and only the concentration on the label tells you which is which. The relation rearranges two ways. If you know the target concentration and the mass, the volume to add is V = m / c. If you know the concentration and the volume drawn, the mass contained is m = c x V. Dimensional analysis catches most slips: mg/mL multiplied by mL leaves mg; mg divided by mg/mL leaves mL.

Choosing a diluent volume is therefore choosing a concentration, and the choice is usually driven by how small a volume you would have to read accurately later. A 5 mg vial in 1.00 mL gives 5.00 mg/mL, in 2.00 mL gives 2.50 mg/mL, in 3.00 mL gives 1.67 mg/mL. The table below shows the full grid for common vial contents. Working backwards, a 15 mg vial needs 3.00 mL of diluent for 5.00 mg/mL, 1.50 mL for 10.00 mg/mL, and 1.875 mL for 8.00 mg/mL, which is an awkward volume to measure and a sign that you should pick a rounder target. Diluting to a rounder number is worth more than diluting to a prettier one, because every subsequent reading inherits the precision of the first.

One refinement matters once the numbers get tight: the lyophilised powder occupies volume too. If you add 2.00 mL of diluent to a vial whose solids displace 0.06 mL, the solution volume is 2.06 mL and 10 mg gives 4.85 mg/mL rather than 5.00, a difference of about 3 percent. That is usually smaller than the uncertainty in the stated vial mass, but it explains why two people using the same nominal recipe calculate slightly different concentrations. Displacement is rarely published for a given product, so treat any correction as an estimate. Rounding matters in the same way: report 1.67 mg/mL, not 1.6666667, and note that if the vial mass carries 5 percent tolerance and the volume 2 percent, the concentration uncertainty is roughly the square root of 25 plus 4, about 5.4 percent. The same grid underlies concentration arithmetic for a retatrutide vial, the equivalent sums on a 5 mg vial, a 15 mg vial worked through and what a reconstitution calculator is actually doing.

Units, Conversions and the Mistakes That Follow

Most disagreements about peptide numbers are unit disagreements. One milligram is 1000 micrograms, and the microgram is written mcg on modern labels and ug on older ones, so a factor of 1000 is lost with a single character. A percent solution is a ratio, not a concentration: 1 percent w/v means 1 g per 100 mL, which is 10 mg/mL, while 0.1 percent w/v is 1 mg/mL. Weight/weight and weight/volume percentages are not interchangeable unless the density is 1 g/mL. International units are the hardest case: an IU is defined per substance against a WHO international standard, so there is no universal IU to milligram factor, and any conversion has to come from the standard or the product's own labelling. This is why unit versus mass for a peptide sold in units is a standards question rather than a maths one.

Syringe barrels add their own layer. A 1 mL syringe graduated in 100 units is marking volume, not mass: one unit equals 0.01 mL. A 0.5 mL barrel carries 50 such graduations and a 0.3 mL barrel 30, sometimes with finer 0.005 mL marks. Reading error is about half the smallest graduation, so plus or minus 0.005 mL on a 1 mL barrel is 1 percent of a 0.50 mL reading but 5 percent of a 0.10 mL reading. Dead volume is a separate effect, since liquid retained in the hub and any attached needle, often 0.05 to 0.1 mL, never appears in the barrel reading. Both are why a target concentration is chosen so the volume to be read sits mid-barrel rather than at its end.

The third class of error is the one calculators cannot see: what the vial actually contains. A powder labelled 10 mg is 10 mg of material as filled, which includes the peptide, the counterion left from synthesis and purification, and residual water. Net peptide content of 80 to 90 percent is unremarkable, so 10 mg as filled may be 8.5 mg of peptide, and every figure calculated from the gross number is correspondingly optimistic. TFA pairs with each basic site, so the counterion count scales with the arginine, lysine, histidine and N-terminal residues. Water is the other variable: a hygroscopic cake exposed to humid air can gain several percent of its mass in minutes, which is why a well-dried product is weighed quickly or by difference. Public calculators such as a general peptide mass and volume calculator and a calculator built around one molecule take the mass you type and nothing else, so they cannot know your vial's net content. Mass and volume arithmetic for other research peptides follows the same rule, and a question about an oral route changes it again, because amount in the vial and amount available after absorption are different quantities measured by different methods.

Cold Chain and Storage Conventions

Two temperature conventions dominate peptide handling, and they are conventions rather than guarantees. Lyophilised powder is commonly shipped and stored frozen, around -20 degrees C, with -80 degrees C used for longer-term archival of some materials. A solution made from that powder is commonly kept refrigerated at 2 to 8 degrees C. The distinction matters because the dry solid and the solution degrade by different routes: in solution, hydrolysis, deamidation of asparagine (which shifts the mass by about 1 Da and is visible by mass spectrometry), oxidation of methionine to the sulfoxide (plus 16 Da) and aggregation all become available. The only authoritative stability statement for any specific product is the manufacturer's own data for that formulation and batch, generated under stability protocols of the kind described in the ICH Q1A(R2) guidance. Everything else is a rule of thumb.

Freeze-thaw cycling is the usual enemy of a reconstituted solution, and the arithmetic of it is simple: a stock vial thawed ten times has experienced ten excursions, while the same volume split into ten aliquots has experienced one each. Aliquoting therefore trades a little handling effort for a large reduction in cycling. The planning is arithmetic as well: number of aliquots times volume per aliquot, plus the dead volume lost to each container and transfer, has to be covered by the stock, and every aliquot should be labelled with concentration, date and batch rather than just a name. Moisture and light are the other two variables: a cold vial opened in warm humid air collects condensate on the powder, so vials are normally allowed to reach room temperature first, and photosensitive residues make amber glass or foil worth the trouble.

Shipping deserves the same documentary attention as storage. Dry ice sublimates at -78.5 degrees C and is gone in a day or two; gel packs hold near 0 degrees C by phase change and then drift. A parcel arriving with no cold mass left is a documented temperature excursion, not proof either way. Photograph the packing, record a thermometer reading if you have one, and put the question to the seller rather than guessing. A cheap data-logging thermometer, typically accurate to about half a degree, turns an argument into a record. The conventions behind each point are laid out in the storage page for powders and solutions and in the question of how long a vial keeps once cold. A different stability regime applies to preserved cosmetic formulas kept at room temperature, covered in the skin peptide hub.

• Lyophilised powder: frozen, commonly about -20 degrees C, with -80 degrees C for long archival storage of some materials.
• Reconstituted solution: refrigerated, commonly 2 to 8 degrees C, protected from light.
• Avoid repeated freeze-thaw: split the stock into single-use aliquots and label each with concentration, date and batch.
• Let a cold vial reach room temperature before opening so moisture does not condense onto the powder.
• Expect frost-free household freezers to cycle through defrost, which is itself a temperature excursion.
• Record excursions with photographs, a thermometer reading and a data logger where one is available.

Freeze-Drying and What a Cake Tells You

Lyophilisation removes water by sublimation rather than by boiling, which is why a heat-sensitive molecule survives it. The cycle has three stages. Freezing takes the formulation below its collapse or eutectic temperature, often to a shelf temperature around -40 to -50 degrees C. Primary drying then pulls a vacuum, commonly at chamber pressures of roughly 0.05 to 0.3 mbar, or about 50 to 300 mTorr, and supplies just enough heat for ice to sublime while the product temperature stays a few degrees below the collapse point; this is the slow stage, and it removes the bulk of the water. Secondary drying raises the temperature under continued vacuum to desorb the water that is bound to the solid, leaving residual moisture in the low single digits of percent, often 1 to 3 percent, measured by Karl Fischer titration or by loss on drying. Vials are then stoppered under vacuum or backfilled with dry nitrogen.

The appearance of the cake is a record of how that cycle went. A well-dried product is a uniform, porous plug that fills roughly the volume of the liquid that was frozen, pale and friable, and it wets and dissolves in seconds. Collapse looks different: the cake has shrunk away from the walls, is dense or rubbery, and may show a glossy skin where the structure gave way because the product temperature exceeded the collapse temperature during primary drying. Meltback is more severe, the result of the frozen plug actually melting and refreezing, and it produces a dense, glassy mass with cracking and a film on the glass. Froth or dried foam climbing the vial neck suggests the product boiled over during drying. None of these is a purity result. Collapse usually means higher residual moisture, slower wetting and possibly more degradation during the cycle, but the only way to know what is in the vial is to run chromatography and a mass spectrum.

Formulation ingredients explain most of the rest. Bulking agents such as mannitol and glycine crystallise during freezing and give a robust, easily dried cake; sucrose and trehalose stay amorphous, hold the peptide in a glassy matrix and are thought to substitute for water at the molecule's surface, which is one reason they are used as lyoprotectants. Their presence also means the powder mass on the label is not all peptide, which loops back to net peptide content. Reconstitution behaviour is a clue too: a cake that takes minutes to dissolve, or that leaves persistent particles, has had a different thermal history from one that disappears on contact, and forcing it into solution risks foaming and shear. The full cycle, with the temperatures and pressures typical of each stage, is set out in the freeze-drying process page.

• Freezing below the collapse or eutectic temperature, often around -40 to -50 degrees C shelf temperature.
• Primary drying under vacuum, roughly 0.05 to 0.3 mbar, removes ice by sublimation.
• Secondary drying desorbs bound water, leaving residual moisture in the low single digits of percent.
• An elegant cake is uniform and porous; collapse is shrunken and dense; meltback is glassy and cracked.
• Mannitol and glycine crystallise into structured cakes; sucrose and trehalose protect through a glassy matrix.
• Cake appearance is a process signal, not a purity measurement: only HPLC and MS answer the purity question.

Purity, Identity and Third-Party Testing

Purity and identity answer different questions and are produced by different instruments. Purity normally comes from reversed-phase HPLC, typically a C18 column run with a gradient of water and acetonitrile containing about 0.1 percent trifluoroacetic acid as an ion-pairing agent, with detection at 210 to 220 nm where the peptide bond itself absorbs. The reported figure is an area percentage: the area of the main peak as a fraction of the total integrated area at that wavelength. That is not a mass percentage. An impurity without a chromophore, or one that elutes in the void volume, or one hiding under the main peak, does not appear; a run at 280 nm only sees tryptophan, tyrosine and, weakly, phenylalanine. A good report names the column, the gradient, the flow rate, the detection wavelength and the sample load, and includes a chromatogram with labelled axes, retention times and an integration table.

Identity normally comes from mass spectrometry. Electrospray ionisation produces a series of multiply charged ions, so a peptide near 4000 Da might appear as charge states at m/z values around 1334, 1001 and 801 for the +3, +4 and +5 ions, deconvoluted back to a neutral mass; MALDI time-of-flight tends to give one dominant singly charged ion. High-resolution instruments report mass error in parts per million, while unit-resolution instruments are nearer a few hundredths of a percent. Matching a mass is necessary but not sufficient: isomers and mass-preserving modifications are invisible to a single MS measurement, and confirming a sequence needs tandem MS or amino-acid analysis. Amino-acid analysis also does something neither of the other two does, which is to give an absolute quantity and therefore a net peptide content.

Two tests that a purity sheet almost never covers are endotoxin and sterility, and they matter whenever material is presented as injectable. Endotoxin is measured by the Limulus amebocyte lysate methods described in USP Chapter 85 and reported in endotoxin units per container or per unit mass or activity; sterility testing is a separate pharmacopoeial method involving membrane filtration or direct inoculation and an incubation period of about 14 days. A 99 percent purity figure says nothing about either. Independent testing adds one valuable thing: a second party's instrument run against a batch, which is what the independent peptide testing page and the purity methods page are about. It does not add chain of custody unless that was arranged, it usually covers a single vial the submitter chose and shipped, and it covers sterility or endotoxin only if those assays were requested and paid for. Whether a supplier publishes batch-matched reports, and how to read them, is the question worked through in one vendor's published documentation as an example.

Reading a Specification Sheet and Spotting Red Flags

A specification sheet is a chain of claims, and each link either supports the next or does not. The product name should resolve: a full sequence, or a CAS number that resolves to one sequence, ties the vial to a molecule; a nickname does not. The batch or lot number should be the same code printed on the vial you hold, since a representative certificate describes some other lot. The purity figure should arrive with its method, since 98 percent on one column at one wavelength is not the same measurement as 98 percent on another. The identity result should show an observed mass against a theoretical one, and the theoretical mass should be one you can check by summing residue masses and adding 18.02 Da for water. Storage conditions and a retest or expiry date close the loop. The table below sets the whole thing out as a checklist.

Naming is where counterfeit and ambiguous material is easiest to spot, and several of the pages under this hub exist for exactly that reason. Vendor shorthand travels faster than scientific nomenclature: reta, glp-3rt, tirz and similar contractions appear on labels long before any standard name exists, and two different molecules can share a nickname across suppliers. The checks are unglamorous and effective: compare the sequence, compare the systematic or chemical name, compare the mass implied by the sequence with the mass on the sheet, and be suspicious when a seller's naming does not match reference listings. the chemical name behind the shorthand, whether one label describes the same molecule as another, how two similar products differ on paper and what a shortened name on a vial actually refers to all work through that comparison.

The red flags are mostly absences. No batch number. A purity percentage with no method, no wavelength and no chromatogram. A chromatogram cropped so that neither axis is readable, or with no integration table. A round figure repeated across every product in a catalogue, which suggests a template rather than a measurement. A representative or generic certificate instead of a batch-matched one. Identity claimed with no spectrum shown. Endotoxin results quoted in units with no method or no units at all. Any statement implying human use on a product labelled research use only, which is the clearest signal that the seller's marketing and the seller's label disagree, and a reason to walk away. For regulatory questions, including counterfeit reports, consult your national regulator; for anything concerning a person, consult a licensed clinician. Regulators including the FDA have repeatedly warned about unapproved and counterfeit products sold outside the licensed supply chain, and no amount of arithmetic on this page substitutes for that check.